ATE437223T1 - Attenuiertes bovines respiratorisches syncytialvirus - Google Patents

Attenuiertes bovines respiratorisches syncytialvirus

Info

Publication number
ATE437223T1
ATE437223T1 AT01938170T AT01938170T ATE437223T1 AT E437223 T1 ATE437223 T1 AT E437223T1 AT 01938170 T AT01938170 T AT 01938170T AT 01938170 T AT01938170 T AT 01938170T AT E437223 T1 ATE437223 T1 AT E437223T1
Authority
AT
Austria
Prior art keywords
respiratory syncytial
bovine respiratory
attenuate
syncytial virus
viruses
Prior art date
Application number
AT01938170T
Other languages
English (en)
Inventor
Ulrike Schmidt
Ursula Buchholz
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Application granted granted Critical
Publication of ATE437223T1 publication Critical patent/ATE437223T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18561—Methods of inactivation or attenuation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Glass Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT01938170T 2000-06-23 2001-05-02 Attenuiertes bovines respiratorisches syncytialvirus ATE437223T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00202183 2000-06-23
PCT/EP2001/005085 WO2002002752A1 (en) 2000-06-23 2001-05-02 Attenuated bovine respiratory syncytial virus

Publications (1)

Publication Number Publication Date
ATE437223T1 true ATE437223T1 (de) 2009-08-15

Family

ID=8171676

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01938170T ATE437223T1 (de) 2000-06-23 2001-05-02 Attenuiertes bovines respiratorisches syncytialvirus

Country Status (9)

Country Link
US (2) US6921535B2 (de)
EP (1) EP1297110B1 (de)
AT (1) ATE437223T1 (de)
AU (1) AU2001263896A1 (de)
CA (1) CA2412075C (de)
DE (1) DE60139319D1 (de)
DK (1) DK1297110T3 (de)
ES (1) ES2330411T3 (de)
WO (1) WO2002002752A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1297110B1 (de) * 2000-06-23 2009-07-22 Intervet International BV Attenuiertes bovines respiratorisches syncytialvirus
US7355716B2 (en) * 2002-01-24 2008-04-08 The General Hospital Corporation Apparatus and method for ranging and noise reduction of low coherence interferometry LCI and optical coherence tomography OCT signals by parallel detection of spectral bands
EA011878B1 (ru) 2003-12-24 2009-06-30 Де Стат Дер Недерланден, Вертегенвордигд Дор Де Министер Ван Волксгезондхейд, Велзейн Ен Спорт Респираторно-синцитиальный вирус с перекрестно компенсированным геномным дефицитом
CN103555670B (zh) * 2004-12-23 2015-08-12 米迪缪尼有限公司 用于病毒增殖的非致瘤性mdck细胞系
EP2069480B1 (de) * 2006-09-15 2014-03-19 MedImmune, LLC Mdck-zelllinien zur unterstützung von virenwachstum auf hohe konzentrationen und bioreaktorverfahren damit
CA2738024A1 (en) * 2008-09-24 2010-04-01 Medimmune, Llc Methods for purification of viruses
BRPI0919252A2 (pt) * 2008-09-24 2015-08-11 Medimmune Llc Métodos para cultivar células, propagação e purificação de vírus
DK2344522T3 (en) * 2008-10-16 2016-04-18 Univ Saskatchewan Combinatorial Adjuvant formulation
AR084358A1 (es) * 2010-12-27 2013-05-08 Lilly Co Eli Composiciones y metodos para identificar y diferenciar componentes virales de vacunas multivalentes de la “fiebre de embarque” (complejo de enfermedad respiratoria bovina (brdc))
CN105734007B (zh) * 2016-03-10 2019-06-07 金宇保灵生物药品有限公司 一种筛选对牛病毒性腹泻/黏膜病毒敏感的mdbk细胞系的方法
AU2020287915B2 (en) * 2019-06-07 2025-05-15 Intervet International B.V. MDBK IRF3/IRF7 knock out mutant cell and its use for vaccine production

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1394259A3 (de) * 1994-07-18 2004-04-14 Karl-Klaus Prof. Dr. Conzelmann Rekombinantes infektiöses nicht-in-Segmente-geteiltes negativ-Strange-RNS-Virus
US6699476B1 (en) * 1996-07-15 2004-03-02 Peter L. Collins Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules
ATE451451T1 (de) 1996-07-15 2009-12-15 Us Gov Health & Human Serv Herstellung von attenuierten respiratorischen syncytialvirus-impfstoffen aus klonierten nukleotidsequenzen
EP0974660A1 (de) 1998-06-19 2000-01-26 Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) Newcastle-Krankheitsvirus Infektiöser Klone, Impfstoffe und Diagnosetest
EP1297110B1 (de) * 2000-06-23 2009-07-22 Intervet International BV Attenuiertes bovines respiratorisches syncytialvirus

Also Published As

Publication number Publication date
US20050186224A1 (en) 2005-08-25
US7335366B2 (en) 2008-02-26
DE60139319D1 (en) 2009-09-03
WO2002002752A1 (en) 2002-01-10
EP1297110B1 (de) 2009-07-22
ES2330411T3 (es) 2009-12-10
AU2001263896A1 (en) 2002-01-14
CA2412075C (en) 2011-09-20
CA2412075A1 (en) 2002-01-10
DK1297110T3 (da) 2009-11-16
US20040037850A1 (en) 2004-02-26
EP1297110A1 (de) 2003-04-02
US6921535B2 (en) 2005-07-26

Similar Documents

Publication Publication Date Title
ATE437223T1 (de) Attenuiertes bovines respiratorisches syncytialvirus
AU4185001A (en) Protein scaffolds for antibody mimics and other binding proteins
Monteil et al. Crimean–Congo haemorrhagic fever virus uses LDLR to bind and enter host cells
DE60023936D1 (de) Methoden zur verwendung von randomisierten zinkfingerprotein-bibliotheken zur identifizierung von genfunktionen
DE60328885D1 (de) Verfahren zur Beurteilung eines Krankheitzustandes mittels Nachweis von partikel- und nicht partikelgebundenen Nukleinsäuren in Blutplasma und -serum
ATE384785T1 (de) Herstellung von viren, virusisolaten, und impfstoffen
PL404537A1 (pl) Wirusy stowarzyszone z adenowirusem, kompozycje, wyizolowane bialko kapsydu, wyizolowana lub syntetyczna czasteczka kwasu nukleinowego, sposób wytwarzania rekombinowanych wirusów, komórki gospodarza, bialka obejmujace fragment bialka kapsydu AAV, sztuczne bialka, rekombinowane wirusy, czasteczki, sposoby dostarczania transgenu do komórki, sposób identyfikacji serotypu sekwencji wirusa (AAV), zestaw diagnostyczny, sposób izolacji nowych wirusów, nowe serotypy wirusa, wyizolowane wirusy, rekombinowana komórka, zastosowanie wirusa
DE60236965D1 (de) Coronavirus-ähnliche partikel enthaltende funktionell deletierte genome
ATE439592T1 (de) Proteingerüste für antikörper-nachahmer und andere bindende proteine
ATE427499T1 (de) Zusammensetzungen und verfahren zur quantifizierung von serumglykoproteinen
DE69942708D1 (de) Virus enthaltende Zusammensetzungen und Methoden zur Konzentration von Viruspräparaten
ATE244771T1 (de) Verfahren zur erkennung von nukleinsäuremethylierungen durch aflp
ATE492813T1 (de) Verfahren zur isolierung von analyten aus einer probe
DK0486515T3 (da) Fremgangsmåde til bestemmelse af den funktionelle aktivitet af frit protein S eller protein C i en plasmaprøve
ATE309540T1 (de) Analytisches verfahren unter verwendung von multipelviren-markierung
DE60034966D1 (de) Auswertung von biologischen mitteln in lebenden zielzellen
ATE487792T1 (de) Verfahren und zusammensetzungen zur identifikation von rna-bindenden proteinen
ATE288589T1 (de) Verfahren zur analyse von proteinen
DE50200452D1 (de) Verfahren zur Testung des hormonellen Effekts von Substanzen
Aggarwal et al. TMPRSS2 activation of Omicron lineage Spike glycoprotein is regulated by Collectrin-like domain of ACE2
Holmes et al. Coronavirus receptor specificity
DE50212790D1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
ATE412180T1 (de) Verfahren und mittel zum nachweis von durch gluten induzierten krankheiten
DE69824001D1 (de) Reagenz zum nachweis und weiterverfolgen von virusinfektionen
DE60040789D1 (de) Verfahren zur aufreinigung heterologer proteine

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1297110

Country of ref document: EP

REN Ceased due to non-payment of the annual fee